pH‐Controlled Delivery of Doxorubicin to Cancer Cells, Based on Small Mesoporous Carbon Nanospheres
- 4 June 2012
- Vol. 8 (17), 2715-2720
- https://doi.org/10.1002/smll.201200217
Abstract
Mesoporous carbon nanospheres (MCNs) with small diameters of ≈90 nm are developed as an efficient transmembrane delivery vehicle of an anticancer drug, doxorubicin (DOX). MCNs exhibit a high loading capacity toward DOX due to hydrophobic interactions and the supramolecular π stacking between DOX and the carbonaceous structures, on which the pH‐dependent drug release are successfully achieved. Specifically, DOX can be loaded onto MCNs in basic solution and in a physiological pH range, while release occurs in acidic solution in its ionized state. By effective passive and active targeting, MCNs can be readily internalized into HeLa cells, where the carried DOX can be efficiently released in the acidic microenvironment of the tumors for further therapy. The endocytosis and cytotoxicity of DOX@MCNs toward HeLa cells are investigated by confocal microscopy and MTT assay. This smart pH‐dependent drug loading and release property of DOX@MCNs makes it possible to reduce the cytotoxicity to normal tissues during circulation in the body since the normal physiological pH is ≈7.4.This publication has 21 references indexed in Scilit:
- Mesoporous Silica Nanoparticles for Intracellular Controlled Drug DeliverySmall, 2010
- Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer TherapyAngewandte Chemie, 2009
- Active targeting schemes for nanoparticle systems in cancer therapeuticsAdvanced Drug Delivery Reviews, 2008
- Supramolecular Chemistry on Water-Soluble Carbon Nanotubes for Drug Loading and DeliveryACS Nano, 2007
- Mesoporous silica nanoparticles deliver DNA and chemicals into plantsNature Nanotechnology, 2007
- A reversible molecular valveProceedings of the National Academy of Sciences of the United States of America, 2005
- A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug MoleculesJournal of the American Chemical Society, 2003
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silicaNature, 2003
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979